COSMOS Pharmaceutical Corporation

CSMYF · OTC
Analyze with AI
5/31/2025
5/31/2024
5/31/2023
5/31/2022
Assets
Cash & Equivalents$57,038$52,301$45,928$37,362
Short-Term Investments$0$0$0$0
Receivables$12,240$12,199$12,650$10,766
Inventory$92,323$86,173$77,479$66,363
Other Curr. Assets$4,021$3,660$13,226$11,548
Total Curr. Assets$165,622$154,333$137,085$115,471
Property Plant & Equip (Net)$348,162$295,798$274,655$239,035
Goodwill$0$0$0$0
Intangibles$446$497$547$433
Long-Term Investments$0$0$4,310$4,179
Tax Assets$2,913$0$2,268$1,966
Other NC Assets$7,608$25,915$2,095$1,966
Total NC Assets$359,129$322,210$283,875$247,579
Other Assets$4$3$7$2
Total Assets$524,755$476,546$420,967$363,052
Liabilities
Payables$177,125$179,549$161,852$139,224
Short-Term Debt$7,938$6,512$4,485$3,056
Tax Payable$11,651$5,572$6,275$4,995
Deferred Revenue$0$0$24,801$18,975
Other Curr. Liab.$23,966$21,596$19,441$14,788
Total Curr. Liab.$220,680$213,229$192,053$162,063
LT Debt$42,019$27,551$13,716$6,357
Deferred Rev, NC$0$0-$442-$451
Deferred Tax Liab, NC$0$0$442$451
Other NC Liab.$4,593$4,325$4,126$4,125
Total NC Liab.$46,612$31,876$17,842$10,482
Other Liabilities$0$0$0$0
Cap. Leases$7,073$6,097$5,442$5,026
Total Liabilities$267,292$245,105$209,895$172,545
Equity
Pref Stock$0$0$0$0
Common Stock$4,178$4,178$4,178$4,178
Retained Earnings$248,309$222,284$202,485$181,954
AOCI$0$0$40$5
Other Equity$4,975$4,978$4,368$4,369
Total Equity$257,462$231,440$211,071$190,506
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$524,754$476,546$420,966$363,051
Net Debt-$7,081-$18,238-$27,727-$27,949
COSMOS Pharmaceutical Corporation (CSMYF) Financial Statements & Key Stats | AlphaPilot